This study found a survival benefit with low-dose vs standard-dose chemotherapy for several common cancer types. The study was published as a preprint and has not yet been peer reviewed.
First Look
This study found a survival benefit with low-dose vs standard-dose chemotherapy for several common cancer types. The study was published as a preprint and has not yet been peer reviewed.
First Look
